A different way to see what’s possible.

We are a biopharmaceutical company focused on reformulating and repurposing established pharmaceuticals. Through research and development, we explore how existing products and technologies can be applied to previously overlooked or underexplored medical challenges.

Our work brings together scientific research, established medicines and proprietary technologies. The aim is to develop thoughtful solutions that can make a meaningful difference for patients and healthcare professionals.

AFYX reports patent-protected technologies and competitive advantages across head and neck cancer, cluster headache, mucosal diseases and labour induction. The company’s research combines reformulation with proprietary patch-based drug delivery.

For AFYX, reversed innovation is a way of thinking: start with what is known, then ask where else it could help.

For Dr. Claus Møller-San Pedro, the motivation to become a doctor was a desire to help people in need. During medical school, it became clear that his future would not lie in clinical practice. A research position at the Protein Laboratory at the University of Copenhagen opened his eyes to opportunities beyond the clinic.

“Early on, I became focused on experimental cancer treatment and immediately started thinking about how research could be translated into pharmaceutical products.”

Dr. Claus J. Møller-San Pedro
Founder & CEO, AFYX Therapeutics